Steve Nevral, Director of Business Development at DisclosedRx, and Zack Robinson, Managing Partner at DisclosedRx, discuss how the company is the first fully disclosed PBM. The fully disclosed model prohibits them from receiving revenue from any source other than their clients. The company’s goal is to return trust between the advisor, TPA, and PBM relationship. Nevral and Robinson break down their model and explain how it’s possible to become a fully disclosed PBM.Support the show (https://healthcareamericana.com/sponsors/)